ACHE and Alzheimer disease: The present results demonstrated that the administration of CV or CV-LN may ameliorate the neurotransmitter balance by raising serotonin levels and decreasing AChE and MAO genes expressions, while also markedly raising the SAP, DI, and DR scores as compared to those in AlCl3-induced AD-like rats (Table 2).